JPMORGAN CHASE & CO - SAGE THERAPEUTICS INC ownership

SAGE THERAPEUTICS INC's ticker is and the CUSIP is 78667J958. A total of 4 filers reported holding SAGE THERAPEUTICS INC in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
JPMORGAN CHASE & CO ownership history of SAGE THERAPEUTICS INC
ValueSharesWeighting
Q2 2021$1,346,000
+14855.6%
23,700
+23600.0%
0.00%
Q4 2020$9,000
+50.0%
1000.0%0.00%
Q3 2020$6,000
-99.8%
100
-99.8%
0.00%
-100.0%
Q2 2020$2,744,000
-49.3%
66,000
-12.0%
0.00%0.0%
Q4 2019$5,414,000
-4.6%
75,000
+110.1%
0.00%0.0%
Q1 2019$5,678,000
+5307.6%
35,700
+3145.5%
0.00%
Q4 2018$105,000
-32.3%
1,1000.0%0.00%
Q3 2018$155,000
-18.0%
1,100
-63.3%
0.00%
Q3 2017$189,0003,0000.00%
Other shareholders
SAGE THERAPEUTICS INC shareholders Q2 2020
NameSharesValueWeighting ↓
GROUP ONE TRADING, L.P. 10,600$444,7760.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
SIMPLEX TRADING, LLC 900$370.00%
View complete list of SAGE THERAPEUTICS INC shareholders